These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22621990)

  • 1. N-terminal PEGylation of human serum albumin and investigation of its pharmacokinetics and pulmonary microvascular retention.
    Zhao T; Yang Y; Zong A; Tan H; Song X; Meng S; Song C; Pang G; Wang F
    Biosci Trends; 2012 Apr; 6(2):81-8. PubMed ID: 22621990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific chemical modification of human serum albumin with polyethylene glycol prolongs half-life and improves intravascular retention in mice.
    Zhao T; Cheng YN; Tan HN; Liu JF; Xu HL; Pang GL; Wang FS
    Biol Pharm Bull; 2012; 35(3):280-8. PubMed ID: 22382312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylation of human serum albumin: reaction of PEG-phenyl-isothiocyanate with protein.
    Meng F; Manjula BN; Smith PK; Acharya SA
    Bioconjug Chem; 2008 Jul; 19(7):1352-60. PubMed ID: 18572961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent.
    Fahrländer E; Schelhaas S; Jacobs AH; Langer K
    Nanotechnology; 2015 Apr; 26(14):145103. PubMed ID: 25789544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human serum albumin dimer has high blood circulation activity and low vascular permeability in comparison with native human serum albumin.
    Matsushita S; Chuang VT; Kanazawa M; Tanase S; Kawai K; Maruyama T; Suenaga A; Otagiri M
    Pharm Res; 2006 May; 23(5):882-91. PubMed ID: 16715378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced plasma expander-like properties as a function of PEG-chains on extension arm facilitated PEGylation of albumin: "mushroom to brush-like" conformational transition of the PEG-albumin conjugate.
    Sahu RK; Nacharaju P; Manjula BN; Acharya SA
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(6):245-56. PubMed ID: 19922165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ethylene glycol)-conjugated human serum albumin including iron porphyrins: surface modification improves the O2-transporting ability.
    Huang Y; Komatsu T; Wang RM; Nakagawa A; Tsuchida E
    Bioconjug Chem; 2006; 17(2):393-8. PubMed ID: 16536471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior plasma retention of a cross-linked human serum albumin dimer in nephrotic rats as a new type of plasma expander.
    Taguchi K; Urata Y; Anraku M; Watanabe H; Kawai K; Komatsu T; Tsuchida E; Maruyama T; Otagiri M
    Drug Metab Dispos; 2010 Dec; 38(12):2124-9. PubMed ID: 20855459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and provides an alternative to HPLC in characterization of protein PEGylation.
    Zheng C; Ma G; Su Z
    Electrophoresis; 2007 Aug; 28(16):2801-7. PubMed ID: 17702059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O2-binding albumin thin films: solid membranes of poly(ethylene glycol)-conjugated human serum albumin incorporating iron porphyrin.
    Nakagawa A; Komatsu T; Huang Y; Lu G; Tsuchida E
    Bioconjug Chem; 2007; 18(5):1673-7. PubMed ID: 17696490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of poly(ethylene glycol) on the solution structure of human serum albumin.
    Ragi C; Sedaghat-Herati MR; Ouameur AA; Tajmir-Riahi HA
    Biopolymers; 2005 Aug; 78(5):231-6. PubMed ID: 15832324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and analysis of mono-PEGylated HSA by hydrophobic interaction membrane chromatography.
    Shang X; Wittbold W; Ghosh R
    J Sep Sci; 2013 Dec; 36(23):3673-81. PubMed ID: 24106126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Packing density of the PEG-shell in PEG-albumins: PEGylation induced viscosity and COP are inverse correlate of packing density.
    Ananda K; Manjula BN; Meng F; Acharya VN; Intaglietta M; Acharya SA
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):14-27. PubMed ID: 21623695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of human serum albumin-modified exendin-4 conjugate via heterobifunctional polyethylene glycol linkage with protracted hypoglycemic efficacy.
    Kim I; Kim TH; Ma K; Lee ES; Kim D; Oh KT; Lee DH; Lee KC; Youn YS
    Bioconjug Chem; 2010 Aug; 21(8):1513-9. PubMed ID: 20715855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A solid-phase adsorption method for PEGylation of human serum albumin and staphylokinase: preparation, purification and biochemical characterization.
    Suo X; Lu X; Hu T; Ma G; Su Z
    Biotechnol Lett; 2009 Aug; 31(8):1191-6. PubMed ID: 19343505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated albumin-heme as an oxygen-carrying plasma expander: Exchange transfusion into acute anemia rat model.
    Huang Y; Komatsu T; Yamamoto H; Horinouchi H; Kobayashi K; Tsuchida E
    Biomaterials; 2006 Sep; 27(25):4477-83. PubMed ID: 16678256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Length and Structure of Attached Polyethylene Glycol Chain on Hydrodynamic Radius, and Separation of PEGylated Human Serum Albumin by Chromatography.
    Akbarzadehlaleh P; Mirzaei M; Mashahdi-Keshtiban M; Heidari HR
    Adv Pharm Bull; 2021 Sep; 11(4):728-738. PubMed ID: 34888220
    [No Abstract]   [Full Text] [Related]  

  • 18. Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain.
    Manjula BN; Tsai A; Upadhya R; Perumalsamy K; Smith PK; Malavalli A; Vandegriff K; Winslow RM; Intaglietta M; Prabhakaran M; Friedman JM; Acharya AS
    Bioconjug Chem; 2003; 14(2):464-72. PubMed ID: 12643758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-Specific Albumination as an Alternative to PEGylation for the Enhanced Serum Half-Life in Vivo.
    Yang B; Lim SI; Kim JC; Tae G; Kwon I
    Biomacromolecules; 2016 May; 17(5):1811-7. PubMed ID: 27050863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cys34-PEGylated Human Serum Albumin for Drug Binding and Delivery.
    Mehtala JG; Kulczar C; Lavan M; Knipp G; Wei A
    Bioconjug Chem; 2015 May; 26(5):941-9. PubMed ID: 25918947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.